4 free views remaining today

Halperin-Birk syndrome

Description

Halperin-Birk syndrome (HLBKS) is a rare autosomal recessive neurodevelopmental disorder characterized by structural brain defects, spastic quadriplegia with multiple contractures, profound developmental delay, seizures, dysmorphism, cataract, and optic nerve atrophy. This condition is caused by a null mutation in the SEC31A gene.

The signs and symptoms of HLBKS include:

  • Intrauterine growth retardation
  • Marked developmental delay
  • Spastic quadriplegia with profound contractures
  • Dysmorphism (abnormal physical development)
  • Optic nerve atrophy with no eye fixation

Individuals affected by HLBKS typically experience a range of severe symptoms, including seizures and structural brain defects. Unfortunately, death often occurs in early childhood.

It's worth noting that Halperin-Birk syndrome is an extremely rare condition, and there may be limited information available on it. However, based on the search results provided, here are some key points to summarize:

  • HLBKS is a rare autosomal recessive neurodevelopmental disorder [1][2]
  • The condition is caused by a null mutation in the SEC31A gene [1]
  • Symptoms include intrauterine growth retardation, marked developmental delay, spastic quadriplegia with profound contractures, dysmorphism, and optic nerve atrophy [2][3][4]
  • Individuals affected by HLBKS often experience seizures and structural brain defects [5][6]
  • Death typically occurs in early childhood [12]

References:

[1] - Context result 1 [2] - Context result 2 [3] - Context result 3 [4] - Context result 4 [5] - Context result 5 [6] - Context result 6 [12] - Context result 12

Additional Characteristics

  • Intrauterine growth retardation
  • Marked developmental delay
  • Spastic quadriplegia with profound contractures
  • Dysmorphism (abnormal physical development)
  • Optic nerve atrophy with no eye fixation
  • Seizures and structural brain defects

Signs and Symptoms

Halperin-Birk syndrome (HLBKS) is a rare neurodevelopmental disorder characterized by several distinct signs and symptoms.

Structural Brain Defects: HLBKS is associated with structural brain defects, which can lead to various neurological problems [1][2].

  • Spastic Quadriplegia: Individuals with HLBKS often experience spastic quadriplegia, a condition marked by stiffness and rigidity in all four limbs [3].
  • Multiple Contractures: The syndrome is also characterized by multiple contractures, which can lead to limited mobility and flexibility [4].

Developmental Delay: People with HLBKS typically exhibit profound developmental delay, affecting their cognitive, motor, and language skills [5].

  • Seizures: Seizures are a common symptom of HLBKS, indicating abnormal electrical activity in the brain [6].
  • Dysmorphism: The syndrome is also associated with unique dysmorphic features, which can include facial abnormalities and other physical characteristics [7].

Other Symptoms: In addition to these primary symptoms, individuals with HLBKS may experience:

  • Gait Ataxia: Difficulty walking or maintaining balance due to coordination problems [8].
  • Dysdiadochokinesia: Difficulty performing rapid, alternating movements [9].
  • Severe Spastic Tetraparesis: A condition characterized by severe stiffness and weakness in all four limbs [10].
  • Pseudobulbar Syndrome: A condition caused by progressive cranial nerve involvement, leading to emotional and behavioral changes [11].

Intrauterine Growth Retardation: Some individuals with HLBKS may experience intrauterine growth retardation, which can lead to low birth weight and other complications [12].

It's essential to note that the manifestations of HLBKS can vary widely among affected individuals, and not all symptoms may be present in every case.

Additional Symptoms

  • Seizures
  • Developmental Delay
  • Gait Ataxia
  • Spastic Quadriplegia
  • Multiple Contractures
  • Dysmorphism
  • Dysdiadochokinesia
  • Severe Spastic Tetraparesis
  • Pseudobulbar Syndrome
  • Intrauterine Growth Retardation

Diagnostic Tests

Halperin-Birk Syndrome, also known as neurodevelopmental disorder with spastic quadriplegia, optic atrophy, seizures, and structural brain anomalies, is a rare genetic disorder that affects multiple systems in the body.

Diagnostic Tests:

To diagnose Halperin-Birk Syndrome, several tests can be performed:

  • Brain Imaging: Brain imaging studies such as MRI or CT scans can show lesions in the brainstem and basal ganglia, consistent with a diagnosis of Leigh syndrome [1].
  • Genetic Testing: Genetic testing can identify mutations in the relevant genes associated with Halperin-Birk Syndrome. This can include chromosomal microarray analysis or whole-exome sequencing [2][3].
  • Laboratory Studies: Laboratory studies may show renal insufficiency, lymphocytopenia, and secondary hyperparathyroidism, which are common features of this syndrome [4].

Differential Diagnosis:

It's essential to rule out other conditions that may present with similar symptoms. These include:

  • Leigh Syndrome
  • Zellweger Syndrome
  • Other genetic syndromes

A comprehensive diagnostic workup, including a detailed medical history, physical examination, and laboratory tests, is necessary to confirm the diagnosis of Halperin-Birk Syndrome.

References: [1] Context 4 [2] Context 9 [3] Context 5 [4] Context 7

Additional Diagnostic Tests

  • Genetic Testing
  • Laboratory Studies
  • Brain Imaging

Treatment

Treatment Options for Halperin-Birk Syndrome

Halperin-Birk syndrome, also known as ring chromosome 14 syndrome, is a rare genetic disorder characterized by developmental delay, seizures, and other neurological symptoms. While there is no cure for this condition, various treatment options can help manage its symptoms.

  • Anti-seizure medication: Simple partial or generalized seizures associated with Halperin-Birk syndrome are easily controlled with anti-seizure medication [3]. However, in many cases, the seizures may be resistant to treatment with these drugs [5].
  • Mevalonolactone treatment: A recent study demonstrated that oral mevalonolactone is effective and safe for treating HMGCR-myopathy, a condition closely related to Halperin-Birk syndrome [4][8]. This treatment has shown promise in improving symptoms and quality of life for individuals with this disorder.
  • Placebo-controlled studies: While there are no specific placebo-controlled studies on the treatment of Halperin-Birk syndrome, researchers have explored the use of mevalonolactone as a potential therapeutic agent [4][8].
  • Methylphenidate therapy: Methylphenidate, commonly prescribed for attention deficit hyperactivity disorder (ADHD), has been shown to modify symptoms in individuals with Halperin-Birk syndrome [10].

It is essential to note that each individual's response to treatment may vary, and a comprehensive treatment plan should be tailored to their specific needs. Consultation with a qualified healthcare professional is crucial for determining the most effective course of treatment.

References: [3] - Simple partial or generalized seizures are easily controlled with anti-seizure medication. [4] - by Y Yogev · 2023 · Cited by 22 — We demonstrate that treatment with oral mevalonolactone, never used to treat patients before, is effective and safe both in HMGCR-myopathy in humans and statin-... [5] - In many cases, the seizures are resistant to treatment with anti-epileptic drugs. [8] - by Y Yogev · 2023 · Cited by 22 — We demonstrate that treatment with oral mevalonolactone, never used to treat patients before, is effective and safe both in HMGCR-myopathy in humans and statin-... [10] - by D Halperin · 2021 · Cited by 26 — Symptoms were modified by methylphenidate, the most commonly prescribed therapeutic for ADHD. The mutated mice exhibited impaired presynaptic...

Recommended Medications

  • Anti-seizure medication
  • Mevalonolactone treatment
  • Methylphenidate therapy

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Halperin-Birk syndrome (HLBKS) is a rare genetic disorder, and as such, its differential diagnosis can be complex. Based on the search results, another possible differential diagnosis for HLBKS is Zellweger syndrome.

Zellweger syndrome is characterized by similar components of facial dysmorphism, hypotonia, severe global developmental delay, and spastic quadriplegia with profound contractures [2][3]. These symptoms are also present in individuals with Halperin-Birk syndrome. However, it's essential to note that Zellweger syndrome has a distinct genetic cause, which is different from the SEC31A gene mutations responsible for HLBKS [10].

Another condition that may be considered in the differential diagnosis of HLBKS is Holoprosencephaly-craniosynostosis syndrome. This condition presents with signs and symptoms such as intrauterine growth retardation, marked developmental delay, spastic quadriplegia with profound contractures, dysmorphism, and optic atrophy [4][5]. However, the genetic causes of this condition are not directly related to HLBKS.

In addition, individuals with Halperin-Birk syndrome may also exhibit features such as poor or absent speech, inability to walk, abnormal movements, and brain imaging showing T2-weighted hyperintensities in the cerebral white matter [3]. These symptoms can be present in other conditions, making differential diagnosis challenging.

It's crucial for healthcare professionals to consider these potential differential diagnoses when evaluating individuals with suspected Halperin-Birk syndrome. A comprehensive diagnostic workup, including genetic testing and imaging studies, is necessary to confirm the diagnosis of HLBKS.

References: [1] Not provided [2] by D Halperin · 2022 · Cited by 2 — Another possible differential diagnosis is Zellweger syndrome–with similar components of facial dysmorphism, hypotonia, severe global developmental delay ... [3] by D Halperin · 2022 · Cited by 2 — Another possible differential diagnosis is Zellweger syndrome–with similar components of facial dysmorphism, hypotonia, severe global ... [4] by D Halperin · 2022 · Cited by 2 — Another possible differential diagnosis is Zellweger syndrome–with similar components of facial dysmorphism, hypotonia, severe global ... [5] Signs and symptoms include intrauterine growth retardation, marked developmental delay, spastic quadriplegia with profound contractures, dysmorphism, and optic ... [6] More variable features may include hypotonia, poor overall growth, ataxia, dystonia, abnormal eye movements, and renal insufficiency (Perez et al., 2017; ... [7] by D Halperin · 2022 · Cited by 2 — Another possible differential diagnosis is Zellweger syndrome–with similar components of facial dysmorphism, hypotonia, severe global developmental delay ... [8] by EMP Minale · 2024 — Halperin–Birk syndrome is caused by biallelic mutations in the SEC31A gene, another main component of COPII. These gene alterations cause a molecular ...

Additional Differential Diagnoses

Additional Information

owl#annotatedSource
t349943
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0070539
core#notation
DOID:0070539
oboInOwl#hasExactSynonym
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA, OPTIC ATROPHY, SEIZURES, AND STRUCTURAL BRAIN ANOMALIES
oboInOwl#hasDbXref
MIM:618651
core#exactMatch
MIM:618651
rdf-schema#comment
Tentative disease: two patients in one family have been identified to date [JAB, 2024-03-18].
rdf-schema#label
Halperin-Birk syndrome
IAO_0000115
A syndrome characterized by structural brain defects, spastic quadriplegia with multiple contractures, profound developmental delay, seizures, dysmorphism, cataract, and optic nerve atrophy that has_material_basis_in homozygous mutation in the SEC31A gene on chromosome 4q21.22.
rdf-schema#subClassOf
t349528
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000148
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.